Lafora diseaseEpidemiology, pathophysiology and management

被引:0
|
作者
Thomas S. Monaghan
Norman Delanty
机构
[1] Beaumont Hospital and Royal College of Surgeons in Ireland,Epilepsy Programme and Consultant Neurologist, Department of Neurology and Neuroscience
来源
CNS Drugs | 2010年 / 24卷
关键词
Vigabatrin; Ketogenic Diet; Zonisamide; Piracetam; Neuronal Ceroid Lipofuscinoses;
D O I
暂无
中图分类号
学科分类号
摘要
Lafora disease is a rare, fatal, autosomal recessive, progressive myoclonic epilepsy. It may also be considered as a disorder of carbohydrate metabolism because of the formation of polyglucosan inclusion bodies in neural and other tissues due to abnormalities of the proteins laforin or malin. The condition is characterized by epilepsy, myoclonus and dementia. Diagnostic findings on MRI and neurophysiological testing are not definitive and biopsy or genetic studies may be required. Therapy in Lafora disease is currently limited to symptomatic management of the epilepsy, myoclonus and intercurrent complications. With a greater understanding of the pathophysiological processes involved, there is justified hope for future therapies.
引用
收藏
页码:549 / 561
页数:12
相关论文
共 50 条
  • [31] LAFORA DISEASE
    TASSINARI, CA
    BUREAUPAILLAS, M
    DALLABERNARDINA, B
    PICORNELLDARDER, I
    MOUREN, MC
    DRAVET, C
    ROGER, J
    REVUE D ELECTROENCEPHALOGRAPHIE ET DE NEUROPHYSIOLOGIE CLINIQUE, 1978, 8 (01): : 107 - 122
  • [32] Electro-clinical features and management of the late stage of Lafora disease
    d'Orsi, Giuseppe
    Di Claudio, Maria Teresa
    Palumbo, Orazio
    Carella, Massimo
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [33] The coagulopathy of sepsis: Pathophysiology and management
    Satran, R
    Almog, Y
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (07): : 516 - 520
  • [34] Pathophysiology and management of hypoglycemia in diabetes
    Sanchez-Rangel, Elizabeth
    Deajon-Jackson, Jelani
    Hwang, Janice Jin
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2022, 1518 (01) : 25 - 46
  • [35] Hyponatremia in cirrhosis: Pathophysiology and management
    John, Savio
    Thuluvath, Paul J.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (11) : 3197 - 3205
  • [36] Melioidosis: Epidemiology, pathophysiology, and management
    Cheng, AC
    Currie, BJ
    CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (02) : 383 - +
  • [37] Poststroke EpilepsyEpidemiology, Pathophysiology and Management
    José M. Ferro
    Francisco Pinto
    Drugs & Aging, 2004, 21 : 639 - 653
  • [38] Gastritis: Pathophysiology and Clinical Management
    Fansiwala, Kush
    Lewis, Michael S.
    Pisegna, Joseph R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (01): : 5 - 8
  • [39] Pathophysiology and management of obesity hypertension
    Sharma, AM
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (07) : A39 - A39
  • [40] Pathophysiology and management of enteric hyperoxaluria
    Desenclos, Jordan
    Forte, Valentine
    Clement, Cecile
    Daudon, Michel
    Letavernier, Emmanuel
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (05)